"But Dr. Old, we already have an antibody!" Reflections on Lloyd Old's "academic biotech" approach for targeted antibodies.
作者信息
Ritter Gerd
机构信息
Ludwig Institute for Cancer Research, New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
出版信息
Cancer Immun. 2012;12:9. Epub 2012 May 1.
Abstract
摘要
相似文献
1
2
The genealogy of SEREX.SEREX的谱系。
Cancer Immun. 2012;12:7. Epub 2012 May 1.
3
[Monoclonal antibodies and cancer].[单克隆抗体与癌症]
Salud Publica Mex. 1985 May-Jun;27(3):213-34.
4
Monoclonal antibody therapy for cancer.
Cancer Chemother Biol Response Modif. 1991;12:147-63.
5
[Monoclonal antibodies as antineoplastic antibodies].[作为抗肿瘤抗体的单克隆抗体]
Nihon Rinsho. 1983;41(4):821-4.
6
[Monoclonal antibody-based design of antitumor drugs: prerequisites and progress].[基于单克隆抗体的抗肿瘤药物设计：前提条件与进展]
Vestn Ross Akad Med Nauk. 2004(12):10-6.
7
Meeting highlights: 5th Annual International Congress on Monoclonal Antibodies in Cancer, August 2005, Quebec City, Canada.会议亮点：2005年8月于加拿大魁北克市召开的第五届单克隆抗体治疗癌症国际年会。
Clin Lymphoma Myeloma. 2005 Sep;6(2):71-6. doi: 10.1016/s1557-9190(11)70371-7.
8
Monoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm.中枢神经系统淋巴瘤的单克隆抗体疗法：一种新兴的治疗模式。
Expert Opin Pharmacother. 2005 Jun;6(7):1107-14. doi: 10.1517/14656566.6.7.1107.
9
Immunotoxin therapy of malignancy.恶性肿瘤的免疫毒素疗法。
Important Adv Oncol. 1992:111-35.
10
Improving the efficacy of antibody-based cancer therapies.提高基于抗体的癌症治疗的疗效。
Nat Rev Cancer. 2001 Nov;1(2):118-29. doi: 10.1038/35101072.
Zotero 插件